
    
      The objectives of the study is:

        -  to evaluate the effect of the repeated loading dose of clopidogrel (600 mg) in addition
           to high dose of clopidogrel continuous therapy (150 mg/day) on the platelet aggregation
           inhibition in patients with myocardial infarction undergoing interventional treatment

        -  to evaluate the safety of the repeated loading dose of clopidogrel (600 mg) in addition
           to high dose of clopidogrel continuous therapy (150 mg/day) in patients with myocardial
           infarction undergoing interventional treatment
    
  